Skip to main content
. Author manuscript; available in PMC: 2013 Jul 5.
Published in final edited form as: Cell Mol Neurobiol. 2011 May 8;31(6):949–959. doi: 10.1007/s10571-011-9697-y

Fig. 1.

Fig. 1

Monitoring MVs. a Scanning transmission electron micrograph of primary human GBM cell (bar 10 µm) (Skog et al. 2008), b Nanosight microscope (Nanosight Ltd.), c Serum MVs diluted 1/5000 and visualized using the Nanosight Tracking Analysis, d Histogram showing distribution of MV diameter in serum sample

HHS Vulnerability Disclosure